Medications for Acute Gvh Disease

2 results
  • jakafi - ruxolitinib tablet

    (Ruxolitinib)
    Incyte Corporation
    Jakafi treats intermediate or high-risk myelofibrosis and polycythemia vera (in adults intolerant of or unresponsive to hydroxyurea). Also indicated for steroid-refractory acute and chronic graft-versus-host disease in adults and pediatric patients 12 and older.
  • orencia - abatacept injection, powder, lyophilized, for solution

    (Abatacept)
    E.R. Squibb & Sons, L.L.C.
    Orencia treats moderately to severely active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis and psoriatic arthritis in patients 2 years and older, and prevents acute graft-versus-host disease in HSCT patients 2 years and older.